Clinical Trials Browser

Phase 3 × Sorafenib × Other hematologic neoplasm × Clear all

NCT07463651 2026-03-11

TROPHY-15

Phase 3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01371981 2025-11-26

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase 3 Active not recruiting

1,645 enrolled 32 charts

Other hematologic neoplasmSarcoma

Leukemia, Myeloid, Acute, Sarcoma, Myeloid

NCT06073730 2023-10-10

Viale-a

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute